Clinical trials show similar safety outcomes including febrile convulsion rates for GSK's and Merck's measles-mumps-rubella (MMR) vaccines

• Asıl Yazarlar: Md Ahsan Habib (Yazar), Michael Povey (Yazar), Giacomo Casabona (Yazar), Tina Singh (Yazar), Remon Abu-Elyazeed (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Taylor & Francis Group, 2023-01-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Combined measles-mumps-rubella (MMR) vaccines produced by GSK (GSK-MMR) and Merck (Merck-MMR) have demonstrated effectiveness and an acceptable safety profile, as documented over decades of post-licensure use in various regions worldwide. In the United States, 2 doses of the MMR vaccine are recommen...